Literature DB >> 20817333

Thrombohemorrhagic complications of myeloproliferative disorders.

Emmanouil Papadakis1, Ron Hoffman, Benjamin Brenner.   

Abstract

Myeloproliferative disorders are commonly associated with thrombohemorrhagic manifestations. The current review highlights recent advances in understanding the epidemiology and pathogenetic mechanisms of thrombotic and bleeding complications. Therapeutic modalities and prophylactic interventions corresponding to the specific disease states are also discussed.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20817333     DOI： 10.1016/j.blre.2010.08.002

Source DB:  PubMed          Journal:  Blood Rev        ISSN： 0268-960X            Impact factor:   8.250


  9 in total

Review 1.  Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis.

Authors:  Karlyn Martin
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

Review 2.  Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions.

Authors:  Hannah Goulart; John Mascarenhas; Douglas Tremblay
Journal:  Ann Hematol       Date:  2022-03-28       Impact factor: 3.673

3.  JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms.

Authors:  S Leah Etheridge; Michelle E Roh; Megan E Cosgrove; Veena Sangkhae; Norma E Fox; Junmei Chen; José A López; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

4.  Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort.

Authors:  Elizabeth M Kander; Sania Raza; Zheng Zhou; Juehua Gao; Anaadriana Zakarija; Brandon J McMahon; Brady L Stein
Journal:  Int J Hematol       Date:  2015-10-06       Impact factor: 2.490

5.  Iron Overload and Platelet Function Defects: Possible Correlation.

Authors:  Abdulkader A Dahi; Ehab Hanafy; Mohammed Al Pakra
Journal:  J Investig Med High Impact Case Rep       Date:  2016-10-26

6.  Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.

Authors:  Sara C Meyer; Eva Steinmann; Thomas Lehmann; Patricia Muesser; Jakob R Passweg; Radek C Skoda; Dimitrios A Tsakiris
Journal:  Biomed Res Int       Date:  2017-06-18       Impact factor: 3.411

7.  [Clinical features and risk factors of vein thrombosis in 259 patients with chronic myelofiberation neoplasms].

Authors:  M J Huang; Z P He; H Y Tian; Y Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14

8.  Case Report: Free-Floating Intracoronary Thrombus: Who Is the Convict?

Authors:  Francesca Mantovani; Ambra Paolini; Andrea Barbieri; Giuseppe Boriani
Journal:  Front Oncol       Date:  2022-03-08       Impact factor: 6.244

9.  Acute duodenal ischemia and periampullary intramural hematoma after an uneventful endoscopic retrograde cholangiopancreatography in a patient with primary myelofibrosis.

Authors:  Chang Ho Jung; Jong Jin Hyun; Dae Hoe Gu; Eul Sun Moon; Jae Seon Kim; Hong Sik Lee; Chang Duck Kim
Journal:  Clin Endosc       Date:  2014-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.